Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.
about
Beneficial effect of combination therapy using an angiotensin-converting enzyme inhibitor plus verapamil on circulating resistin levels in hypertensive patients with type 2 diabetes.Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.Correlation between levels of circulating adipokines and adiponectin/resistin index with carotid intima-media thickness in hypertensive type 2 diabetic patients.Combination therapy in the treatment of hypertension.
P2860
Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Impact of trandolapril therapy ...... e 2 diabetes and hypertension.
@en
Impact of trandolapril therapy ...... e 2 diabetes and hypertension.
@nl
type
label
Impact of trandolapril therapy ...... e 2 diabetes and hypertension.
@en
Impact of trandolapril therapy ...... e 2 diabetes and hypertension.
@nl
prefLabel
Impact of trandolapril therapy ...... e 2 diabetes and hypertension.
@en
Impact of trandolapril therapy ...... e 2 diabetes and hypertension.
@nl
P2093
P2860
P356
P1476
Impact of trandolapril therapy ...... e 2 diabetes and hypertension.
@en
P2093
Alberto F Rubio-Guerra
Bruno A Escalante-Acosta
David Castro-Serna
German Vargas-Ayala
Hilda Vargas-Robles
Leticia Rodríguez-Lopez
P2860
P304
P356
10.1177/1753944711415307
P577
2011-07-07T00:00:00Z